CTOs on the Move

Nephron Pharmaceuticals

www.nephronpharm.com

 
Nephron Pharmaceuticals Corporation is a mid-sized company that manufactures generic respiratory medications. NPC sells to many classes of trade, including, but not limited to, hospitals, pharmacies, long term care facilities, home care companies and mail order pharmacies. These medications are used in the treatment of asthma and COPD.
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Biodesix Inc

Biodesix Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Biodesix Inc is based in Broomfield, CO. You can find more information on Biodesix Inc at www.biodesix.com

SleepImage

SleepImage Ring The SleepImage Rings stream data to the SleepImage Mobile App for upload, offering the highest level of comfort and convenience. SleepImage Mobile App The SleepImage Mobile App collects sleep data and  automatically uploads it in the mo...

Swisher Hygiene

Swisher Hygiene is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Charlotte, NC. To find more information about Swisher Hygiene, please visit www.swisherhygiene.com

KAI Research

KAI Research is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.